Friday, June 21, 2024
    HomeTelanganaInnovative Paediatric HIV Drug Launched by Laurus Labs in Hyderabad

    Innovative Paediatric HIV Drug Launched by Laurus Labs in Hyderabad

    Related stories

    Telangana Cabinet Approves Crop Loan Waiver for Farmers

    The state cabinet of Telangana, led by Chief Minister...

    Chandrababu Naidu takes oath as MLA in Andhra Pradesh for the ninth time

    Vedic scholars blessed Chandrababu Naidu as he entered his chamber for the fourth time as Chief Minister

    Laurus Labs, a pharmaceutical and biotechnology company in Hyderabad, received approval from the United States FDA to launch the world’s first Oral Dispersible Film (ODF) drug, Dolutegravir, for treating HIV/AIDS in children and infants. The drug is presented as a second option for managing symptoms that align with the disease, and is currently available in pill and liquid suspension form. The ODF technology will simplify drug administration for children, ensuring strict compliance and adherence in HIV treatment.

    The prevalence of HIV among children is considerably higher than adults, with almost 1.7 million children under the age of 14 identified as HIV-infected according to WHO statistics in 2021. In India, an estimated 69,808 children under the age of 15 were afflicted with HIV, representing three percent of the overall HIV-infected population in the country. Adult HIV prevalence has declined since the epidemic’s peak in 2000, with the northeast region states having the highest prevalence rates. The number of People Living with HIV (PLHIV) in India is estimated at around 24 lakhs.

    Also read:  Three arrested after TGCSB exposes cybercrime network
    - Advertisement -
    Rajesh M
    Rajesh M
    Latest News from Hyderabad, Telangana, India & World!

    Follow us


    Contribute News

    You can contribute an article to Telangana Tribune by dropping a mail at

    Latest stories


    Please enter your comment!
    Please enter your name here